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activity (PRA) was normal; exchangeable body sodium and blood
volume, determined in three patients, were also not increased. Four
patients had renal venous renin ratios of hydronephmtic kidney
(HK)/contralateral kidney (CK) > 1.5, which suggests increased
renin release from the diseased kidney, and they had ratios of CKJ
peripheral blood < 1.2, which indicates suppressed renin produc-
tion in the CK. Nephrectomy normalized blood pressure in each of
these patients. Two patients had renin ratios HKJCK a 1.3 and/or
ratios CK/penphery> 1.2; the latter suggests ischemia of the CK.
Pyeloplasty and/or nephrectomy failed to improve the hyperten-
sion. Postoperative changes in blood pressure correlated with
changes in PRA (r = 0.90; P < 0.01). These data suggest that
hypertension associated with unilateral hydronephrosis is partly
dependent on inappropriate activity of the renin-angiotensin sys-
tem; and renal vein renin values are helpful in selecting patients for
surgery.
Comparative study on the antihypertensive effect of propranolol
and metoprolol and their combination with a potassium-sparing
diuretic. H. Witzgall, D. Klaus, S. Hassan-Ali, and J. Zehner.
Medical University Clinic Innenstadi, Munich, F.R.G. Patients
with benign essential hypertension were treated twice daily with 80
mg of propranolol (N = 53;patient age 42 11 yr) or with 100mg
of metoprolol (N = 35; patient age 38 4 yr) for three weeks.
Nonresponders received, in addition, a diuretic (50mg of triamter-
ene, 25 mg of hydroehlorothiazide) for a further three weeks.
Under propranolol, there were 51% responders; under metoprolol,
46%. The combination of beta-receptor blockers with the diuretic
resulted in decrease of blood pressure in propranolol and metopro-
lol nonresponders. No statistical difference was obtained between
groups. After propranolol treatment, there was a significant de-
crease in heart rate (P < 0.0005). Metoprolol-treated patients,
however, showed no significant suppression of pulse rate. Plasma
renin activity (PRA) was significantly lowered by propranolol (P <
0.005, P < 0.0025). Under metoprolol, only basal PRA was sup
pressed (P <0.05). Basal and stimulated plasma aldosterone (PA)
was not influenced dunng beta-receptor blocker regimes. Aldoste-
rone excretion was slightly depressed after treatment with pro-
pranolol and metoprolol. Under beta-blockers, plasma potassium
increased a small amount (P <0.05). Behavior of dopamine-beta-
hydroxylasis was not influenced by the drug therapy. All drugs
exhibited no important side effects. Conclusions. 1) Propranolol
and metoprolol are equipotent antihypertensive drugs. 2) Propran-
olol suppresses heart rate more effectively than does metoprolol.
3) Additional administration of diuretic to nonresponders results in
decrease of blood pressure. 4) Propranolol depresses renin-secre-
tion more pronounced than metoprolol does. 5) Under beta-recep-
tor blockage, a dissociation of renin-aldosterone system was ob-
tained. 6) Beta-blockers induce a slight increase in plasma
potassium during short-term administration.
Stimulation of renin and aldosterone secretion by short- and
long-term regulation systems. J. Zehner, H. Ebel, and D. Klaus.
Medical Policlinic, University Marburg, F.R.G. Renin secretion is
a short-term regulator of blood pressure (BP) homeostasis, and
aldosterone is a long-term regulator. The question arises as to
whether there exist different time regulations for sodium loss, too.
Therefore, we compared the influence of different diuretic sub-
stances on plasma renin activity (PRA) and plasma aldosterone
concentration (AK). Results. a) 10 mm after i.v. application of
0.48 g of theophylline, PRA is increased twofold, whereas AK is
unchanged. b) Clopamide and hydrochiorothiazide do not influ-
ence PRA within 4 hr. AK, however, is stimulated within 2 hr. c)
After 40 mg of ethacrynic acid or 20 mg of furosemide i.v., PRA is
increased within 15 mm and decreases during the subsequent 30
mm nearly to the basic level and does not change for the following
3 hr. AK shows the same kinetic pattern, reaching its highest level
15 mm later than PRA. We conclude that sodium loss influences
renin secretion only after several hours, as is shown by the effect
of clopamide and hydrochiorothiazide (long-term regulation). The
quick increase of PRA within a few minutes after administration of
furosemide and ethacrynic acid is probably not caused by sodium
loss, but acts as an intrarenal servomechanism (short-term regula-
tion). Aldosterone secretion has a more sensitive and earlier reac-
tion to sodium loss than does renin liberation. Aldosterone is
therefore a relatively short-term regulation system of sodium loss.
Furthermore, our results give more evidence for the dissociation
of the renin-angiotensin system and the aldosterone system under
various conditions.
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The effect of propranolol on mean blood pressure (MBP), and
plasma and renal renin in nascent one-kidney Goldblatt (lk-G)
hypertension in rats. J. Atkinson, E. J. Kirchertz and L. Peters-
Haefeli. Institut de pharmacologie de 1' Université, Lausanne,
Switzerland. As propranolol will diminish MBP and plasma renin
level (PRL) in normotensive rats, it was of interest to determine its
effects in early lk-G hypertension, during which the rise in MBP is
thought to be largely renin-angiotensin-dependent. Twenty-four
hours after dorsal aorta cannulation and uni-nephrectomy, contin-
uous MBP recording via the aortic cannula was started, and after
stabilization, a blood sample for PRL was taken. Rats were then
injected with 1 (group P1) or 3 (P3) mg/kg L-propranolol (P) or
saline (C) and 30 mm later underwent renal artery clipping (RAC,
clip 0.2 mm) or a sham (SH) operation. Blood samples were taken
at 45, 90, 180, and 360 mm after operation; MBP was recorded
continuously, hi C rats, RAC and SH induced a peak in PRI at 45
min(C —* RAC: +520%, P <0.001; C —* SH: +180%, P <0.05).
PRL then fell to pre-operative values in SH rats but remained
elevated in RAC (6 hr: +200%, P < 0.05). MBP fell initially, then
rose back to pre-operative values in SH, but went beyond this in
RAC (142 3 at 6 hr from 117 2 mm Hg pre-operative P <
0.001). After pre-treatment with propranolol, the PRL peak seen in
C — SH rats was abolished, but not that after RAC: the latter
"peak" was extended, values at 3 hr in P — RAC being signifi-
cantly higher than those in C — RAC. In P —* RAC rats, there was
an increase in MBP at 45 mm, MBP values at 45 and 90 (P1 —
RAC) and at 45, 90, and 180 mm (P3 —* RAC) being significantly
higher than in C — RAC. Clipping the artery caused an increase in
kidney wet weight (+46%) and a decrease in renal renin concentra-
tion; these effects were attenuated by propranolol pre-treatment.
Thus, propranolol did not block the liberation of renin after RAC,
and it potentiated the subsequent rise in MBP.
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Increased ratio between serum /3 and a-lipoproteins during
diuretic therapy. G. Baumgartner, Z. Glück, P. Weidmann, E.
Peheim, and J. Flammer. Medizjnische Poliklinik, University of
Berne, Switzerland. Increases in serum triglyceride (TG) or cho-
lesterol levels (Ch) during administration of chiorthalidone or furo-
semide have been reported. No data are available on electropho-
retic lipid fractions during diuretic therapy. Since increased TG,
Ch, and/or /3-lipoproteins (f3-LP) may enhance, while high s-
lipoproteins (a-LP) may lower, the risk of coronary heart disease,
these parameters, as well as plasma volume (131 1-RISHA), blood
pressure, and plasma potassium, were evaluated in 5 normal sub-
jects and 11 patients with uncomplicated labile hypertension: 1)
during placebo conditions, and 2) after 4 weeks of chiorthalidone
(C), 100 mg/day, furosemide (F), 80 mg/day, or mefruside (M), 50
mg/day, administered successively in cross-over design. Basal
values and diuretic-induced changes were comparable in normal
subjects and patients, allowing joint analysis. All three diuretics
tended to increase TG and Ch, and significantly increased /3-LP,
while cs-LP remained unchanged (Table). These alterations were
not related to changes in plasma volume, blood pressure or de-
creased plasma potassium.
A Tg, A Ch, Aa-LP, A/3-LP, A/3/a-LP,
Drug % % % % %
C 10±8 4±3.5
F 16± 12 73*
M 14±10 5±3
—4 4 13 6* 18 8* * P<0.05
—2±5 l9±6** 26±9* **P<0.01
7±7 15±6* 14± 10
These data indicate that diuretics may increase the ratio between /3
and a-LP. This side effect is consistent with the possibility of an
increased risk of coronary disease, which could partly offset the
beneficial effects of a lowered blood pres sure in diuretic-treated
patients with hypertension.
Effects of oral administration of phenylmercuric acetate during
three months on renal functions in rats. J. Biollaz, G. Peters, and
J. Diezi. Institut de Pharmacologie de 1' Université, Lausanne,
Switzerland. 96 male and female adult Wistar rats were given,
during three months, phenylmercunc acetate in drinking water, at
two concentrations, resulting in an average daily intake of 1.4 g
(group 1) or 137 g (group 2) of mercury. Controls received
sodium acetate in water. The following measurements were then
made, in unanesthetized animals infused i.v. with isotonic saline at
0.1 mI/mm: inulin clearance (C1), CPAH, C,,ra, CNa. In addition,
maximal urine osmolality after 48 hr of dehydration, changes of
kidney weight, and of renal tissue concentration of DNA, RNA,
and protein were evaluated. With a daily intake of 1.4 j.g Hg, the
concentration of DNA in cortical and medullary renal tissue of
female rats was significantly higher than in controls; no other
change was detected at this dose. In animals receiving the larger
dose, Cm, CPAH, and renal wet weight increased in respect to
controls. No other change was seen. Half of the rats of each group
were then injected with glycerol (10 ml/kg, i.m.), in order to
investigate whether pretreatment with organic Hg affects the de-
velopment of renal lesions after glycerol. Eight days after glycerol,
C1 and CPAH were decreased in all groups to 50 to 60% of the base
values. Cm and CPAH, however, remained significantly higher in
group 2 than in controls, as observed before glycerol. It is con-
cluded that intake by rats of phenylmercunc acetate at doses near
or similar to those ingested by exposed human populations does
not alter overall kidney functions, but induced a significant in-
crease of renal tissue DNA content. At levels of x 100, larger,
significant changes of kidney function were detected.
Strongyloidiasis after renal transplantation. J. Briner, J. Eckert,
D. Frei, F. Largiadèr, and U. Binswanger. Inst it UtfürPathologie,
Departement für Innere Medizin, Chirurgische Klinik A und Insti-
tut für Parasitologie der Universität Zurich, Switzerland. A 50-yr-
old Swiss male received in September 1976 a cadaver allotrans-
plant for renal failure due to adult polycystic kidney disease. Past
history revealed malaria at age 20, when he was living in a tropical
area, and pulmonary tuberculosis at age 20. Hypertension, ery-
throcytosis, and proteinuria were first noted in 1971, and dialysis
was started in 1975, at which time episodes of unexplained blood
eosinophilia were observed. Mild acute rejection crisis was suc-
cessfully treated 4 weeks after transplantation, but at 6 weeks
bilateral pneumonia developed. Despite vigorous antibiotic and
tuberculostatic therapy, the patient died in septic shock. Autopsy
revealed strongyloidiasis with massive granulomatous inflamma-
tion of lungs and bronchi due to larvae of Strongyloides stercoralis
as well as adult female worms, eggs, and free larval stages in the
small intestine.
Uroepithelial tumors and analgesic abuse. F. P. Brunner, L.
Richtmann, G. Thiel, and U. C. Dubach. Departement Innere
Medizin, Universität Basel, Switzerland. Hultengren et al (1965)
first suggested that analgesic abuse could cause uroepitheial tu-
mors with or without analgesic nephropathy. An increasing num-
ber of cases have since been reported from many parts of the
world. In the medical department of the University Hospital in
Basel, we found (1966-1976) records of 20 patients with association
of analgesic nephropathy and tumors of the urinary tract (exclud-
ing hypernephroma). 17 patients (mean age:58 years; 9 females, 8
males) had uroepithelial tumors (11 renal pelvic tumors with 2
recurrences in the bladder, 1 ureteral, and 5 bladder tumors); 1
patient had a sarcoma of the kidney, 1 a sarcoma of the bladder,
and 1 a chorioepithelioma of the kidney. Macroscopic hematuria
was observed in at least 12 of the 17 uroepithelial tumors and often
was falsely attributed to papillary necrosis. Signs of ureteral ob-
struction were present in 5 and urinary retention occurred in 4
patients. Cumulative survival was 65% at 1 yr and 39% at 3 yr; 9 of
the 17 cases, however, were not dialyzed nor operated upon. 43
patients with uroepithelial tumors without analgesic abuse, ob-
served during the same period in the same medical department,
had a mean age of 66 yr and a cumulative survival of 77% at 1 yr
and 53% at 3 yr. These survival rates do not compare unfavorably
with those of the population (age range, 55-64 yr) treated by
dialysis in Swiss hospital (1965— 1975) which showed 87% and 55%
survival at 1 and 3 yr, respectively. Of the 116 patients dialyzed in
Basel from 1970 to October 1977, 42 were thought to have analge-
sic nephropathy. Five of these 42 had uroepithelial tumors at some
time, while no tumor was found in the 74 patients with other
causes of chronic renal failure. Phenacetin, a common ingredient
in analgesic mixtures, has been implicated as being carcinogenic.
Animal experiments showed that 2-hydroxylated and areneoxyde
metabolites of phenacetin and paracetamol might cause malig-
nancy. There is also evidence that metabolites such as N-hydroxy-
phenetidine or N-hydroxy-phenacetin are potent carcinogens. Di-
methylnitrosamine formed from aminophenazone could poten-
tially act as a very potent carcinogen. However, aminophenazone
is not a common ingredient of analgesic mixtures in Australia
where the incidence of uroepithelial tumors appears to be just as
high as in Sweden, where abuse of aminophenazone-containing
analgesics has been massive.
Salmonella-induced urinary infection. R. Delaloye, J. D. Pi-
guet, and J. Fabre. Policlinique universitaire de médecine et
Service de bactériologie de l'Institut d'hygiene, Geneva, Switzer-
land. Between 1964 and 1976, we collected 17 cases in which a
Salmonella was identified in urine, in most cases repeatedly. Seven
infections were due to S. typhimurium (group B), 4 cases were due
to group C, 3 to group D, and 3 cases to group E. S. typhi was
never identified. Only 8 patients suffered from gastroenteritis at
the time of infection, and in 7 of these cases the same agent was
identified in both stool and urine analysis. Collection of urine
samples by catheter and/or repetition of culture seem to indicate
that there was no contamination of samples. Only 4 patients had
urinary symptoms and leucocyturia, 6 had asymptomatic leucocy-
tuna, and 4 had fever. In 9 cases, a lesion of the urinary tract could
be shown to exist. Treatment with ampicillin or cotrimoxazole was
undertaken in 13 cases, and urinary cultures became negative in all
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but one of these cases, who continued to show S. manhattan in his
urine and became an asymptomatic carrier. It may be concluded
that urinary infection caused by Salmonella of groups B, C, D or E
is not exceptional. The involvement of the urinary tract is most
often the only detectable localization of the disease. The clinical
picture is comparable to that observed with urinary infections
caused by the more usual enteric bacilli.
Cause of death in a prospective study (1968—1975) on abuse of
analgesics containing phenacetin and kidney disease. U. C. Do-
bach and M. Grossenbacher. Medizinische Universithts-Polikli-
nik, Department of Internal Medicine, Kantonsspital Basel, Switz-
erland. In a prospective epidemiological, long-term study (1968—
1975), a group of 623 women, 30 to 49-yr-old, with known abuse of
analgesics containing phenacetin (urinary control for presence of
N-acetyl-P-aminophenol), showed a significantly higher mortality
in comparison with an equivalent control group: 21 women of the
study group died, but only five of the control group died (P <
0.05). Autopsy records were available for seven of the eight
women with proven kidney disease. Two women of the study
group died of interstitial nephritis; both belonged to a sub-group
with marked and continuous abuse of analgesics. In this sub-group
there was one death due to an urothel carcinoma of the bladder,
possibly in direct relation to analgesic abuse. Another four cases
showed distinct and pronounced kidney disease: three with an
inflammatory and one with a non-inflammatory affection. Only one
out of five dead persons in the control group had kidney disease
(unilateral small kidney). Compared with a collective of dead
women taken from Year Book of Statistics, Canton of Basel-Stadt
1975, there was a marked predominance in the study group of
kidney disease, as well as a higher incidence of death from various
carcinoma and cardiovascular diseases.
Behavior of gentamicin in the kidney after repeated injections:
Influence of quinine. J. Fabre, M. Rudhardt, and P. Chauvin.
Policlinique de Médecine, Département de Médecine, Université
de Genève, Switzerland. Available data on accumulation and per-
sistence of aminosides in the kidney was established in situations
very different (supratherapeutic dosages or single injection) from
those observed in patients. For a better understanding of this
problem, Wistar rats received daily i.p. injections of 4 mg/kg of
gentamicin (0) for 21 days. They were sacrificed at varying inter-
vals by groups of 6 during treatment and up to 15 weeks after the
last injection. 0 was bioassayed in the serum (peaks: 6—8 ig/ml),
urine, renal cortex, and medulla. Mean concentrations of G in the
cortex were 123 g/g 6 hr after the first injection, 356 g/g on the
7th day, and remained at that level until the end of treatment. They
then decreased very slowly, still averaging 22 g/g 15 weeks after
the last injection. The decrease of cortical concentrations slowed
progressively: its half-life was approximately five days during the
first week, and reached more than 50 days between the 4th and the
8th week. The persistence of Gin the medulla was similar but at a
lower concentration (maximum: 53 /Lg/g). G could still be detected
in the urine 4 weeks after the end of treatment. No changes in
creatinine clearance, proteinuria, lysozymuria, BUN, serum Na,
K, Ca, Cl, and CO2. or (or minimal) histologic lesions of the kidney
were found. These findings differ from the effect of supratherapeu-
tic dosages (60 pg/kg/day for 15 days) observed by Luft et al, who
saw an important nephrotoxicity, although the concentrations in
the cortex were only slightly higher (500—700 jsg/g) than in our
study (224—508 g/g). The association of 30 mg/kg of quinine, an
organic cation, causes an increase of G concentrations in the
cortex (P <0.05 at 1, 6, and 72 hr, and P <0.001 at 24 hr after a
single injection). These observations show that G concentrations
in the cortex persist for a very long time at levels high enough to
provoke the organelle injuries described by Fillastre et al: they
explain why nephrotoxicity of G involves primarily the cortex, is
related to duration of treatment, and persists for many weeks; they
lead us to think that the concentration of G in the cortex as a whole
is an important but probably not the only cause of toxicity. In our
experimental conditions, quinine did not seem to be able to pre-
vent nephrotoxicity of G.
Autoimmune hematological disease with infraclinical systemic
lupus erythematosus in 4 patients: A follow-up of 27 years. H.
Favre, P. A. Miescher, and F. Chatelanat. Division de Néphrolo-
gie et d'Hématologie clu Département de Médecine et Department
de Pathologie, Université de Genève, Switzerland. Four patient,
with idiopathic thrombopenic purpura (ITP) or autoimmune hemo-
lytic anemia (AHA) have developed antinuclear antibodies and
circulating immune complexes (Clq-BA test) associated with the
LE phenomenon in one patient. Analysis of kidney tissue from
these 4 patients showed the following: 1) Immunofluorescent stud-
ies: granular deposits of IgG, 1gM, and C3 along the basement
membrane in 3 patients. 2) Optic microscopy: two patients had
normal glomeruli, one a focal glomerulonephritis (GN), one a mild
diffuse proliferative GN. 3) Electron microscopy: all patients
exhibited mesangial and/or subendothelial deposits. The patients
have been followed from 18 to 37 yr since the beginning of their
disease without any clinical evidence of SLE, although the immu-
nological and anatomical findings in their glomeruli were compati-
ble with a SLE. These cases seem to be a human equivalent of the
black NBZ mouse which has hematological and some other disor-
ders pertaining to SLE without developing the full clinical picture
of SLE.
Renal and urinary tract manifestations of cantharidin-intoxica-
tion. H. P. Fisch, F. W. Reutter, and F. Gloor. Medizinische
Klinik B and Institute of Pathology, Kantonsspital, St. Gallen,
Switzerland. Canthandin, the active principle of Cantharis vesica-
toria, is a very potent irritant of mucous membranes. After oral
ingestion, cantharidin is readily absorbed by the gastrointestinal
tract and excreted by the kidney, irritating the entire urinary tract
with resulting cell damage of various extent. During the past years,
5 cases of cantharidin-intoxication were observed. Cantharidin
was swallowed by 2 males and 3 females as an aphrodisiac (4
cases) or an abortive agent (1 case) in a dose of 10 to 50 mg.
Urgency, frequency, dysuria, and microscopic hematuna occurred
in all. Gross hematuria occurred in 4 patients. In a 16-yr-old girl,
polyuric renal failure developed with an increase of serum creati-
nine to 5.8 mg/dl. Renal function returned to normal within 8 days.
Percutanous renal biopsies were performed in 2 cases on the 4th or
5th day after ingestion of the toxin. In light and electron micros-
copy, minor, unspecific degenerative changes were present in
glomerular cells. The proximal and distal cortical tubules were
distended and showed moderately severe necrobiotic epithelial
alterations, interpreted as direct toxic damage by cantharidin. No
erythrocyte casts were present in the tubular lumen. Inflammatory
changes could not be observed in the renal biopsies. The myth that
cantharides are aphrodisiacs should be eradicated, and the use of
these highly toxic substances should be discouraged vigorously.
Acute leukemia after kidney allotransplantation. D. Frei, J.
Briner, J. Fehr, C. Sauter, F. Largiadèr, and U. Binswanger.
Departement für Innere Medizin und Chirurgische Klinik A der
Universität, Zurich, Switzerland. Two more cases of acute leuke-
mia, in addition to that described in the literature, were observed
10 and 5 yr after successful renal allotransplantation. Patient 1, a
29-yr-old farmer, had an acute lymphatic leukemia resistant to
treatment with vincristine and prednisone. After a short remission,
induced by cytarabine and daunorubicin, relapse occurred and was
resistant to bleomycin, doxorubicin, vinblastine, and dacarbazine.
Death followed interstitial pneumonia. Patient 2, a 47-yr-old sales-
man, developed pancytopenia and hepato-splenomegaly. After
splenectomy, an atypical myeloid leukemia became apparent,
which was not treated because of withdrawal of the patient. He
died 2 months after diagnosis, from unknown causes. Both pa-
tients received a long-term immunosuppressive therapy with 10 mg
of prednisone and 200mg of azathioprine daily. The treatment was
stopped in patient I, but continued in patient 2. A relationship
between the immunosuppression and occurrence of acute leuke-
mia can be postulated, but not proven.
Influence of hypertension on morphology and permeability of
aortic endothelial cells. G. Gabbiani, G. Elemer, M. C. Badonnel,
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and M. B. Vallotton. Departement de Pathologie, Université de
Genève, McGill University, Montreal, Canada, Division
d'Endocrinologie, Department de Médecine, Université de Ge-
nève, Switzerland. Effects of hypertension and alterations in the
renin-angiotensin system on ultrastructure and permeability of rat
aortic endothelial cells were assessed in the following experiments.
Hypertension was produced in one group of animals by constrict-
ing the aorta between the renal arteries and in others by unine-
phrectomy combined with chronic sodium-loading. A third group
of rats received a sodium-restricted diet.Each animal received 5
mg/100 g of body wt of horseradish peroxidase (HRP) i.v. over a
21/2 mm period, during which blood pressure (BP) was monitored.
Plasma renin activity (PRA) was measured by radioimmunoassay.
Seven days after aortic constriction, PRA and BP were signifi-
cantly elevated, the aortic endothelium contained many contractile
ifiaments, and the permeability to HRP was increased, compared
to untreated controls. In animals studied 40 days after ligature, BP
was still increased, but PRA was normal. Neither filaments nor
increased permeability to HRP were observed. In the uninephrec-
tomized, salt-loaded rats, BP was normal at 7, but elevated at 40
days. PRA, however, was always low and neither filaments nor
increased HRP permeability occurred. In contrast, animals receiv-
ing a sodium-restricted diet, who were normotensive but mani-
fested increased PRA, demonstrated increments in both filaments
and HRP permeability. These results demonstrate that the reaction
of aortic endothelial cells to hypertension depends on the etiology
of the disease rather than on the BP per Se. The correlation
between PRA, filaments and permeability to HRP, suggests a
relationship between the activity of renin-angiotensin system and
the type of endothelial reaction.
Does spironolactone directly affect aldosterone secretion? R. C.
Gaillard, A. M. Riondel, M. B. Vallotton, and P. Chabert. Divi-
sion d'Endocrinologie, Département de Médecine, Hópital Can-
tonal, Genéve, Switzerland. The administration of spironolactone
(S) to low-renin hypertensive patients produces an increase in
urinary aldosterone (A) and plasma renin activity (PRA). This
effect has not been thoroughly documented in normal patients.
Erbler observed an inhibition of A biosynthesis after S (in viva
studies), and a S dose-dependent inhibition of A production after
stimulation by ACTH (in vitro studies). The effect of S was studied
in normal patients on a 120 mEq Na/day diet. In group I, 400mg of
S was given for 3 days (N = 8), in group II (N = 5) 1 mg of long-
acting ACTH i.m. was given; and in group III (N = 4) 400mg of S
+ 1 mg long-acting ACTH i.m. were given for I day. Electrolytes,
urinary A, and 17 ketogenic steroids (17KGS), plasma A, PRA,
and cortisol have been measured. Aldosterone secretion was de-
termined in five subjects of group I. S induced a rapid and parallel
stimulation of A and PRA in group I (mean + SEM):
Control day Day 3
Plasma A, ng/100 ml N = 8 8.3 1.8 53.2 8.6
PRA, ag/mi/hr N = 8 1.0 0.2 9.4 2.4
Urinary A, pg/24 hr N = 8 9.5 4.3 47.4 7.1
A secretion, p.g/24 hr N = 5 108.6 23.7 424.0 94.6
No difference in aldosterone and 17KGS excretion pattern was
observed between group II and III. In conclusion, no inhibitory
effect of spironolactone could be demonstrated on A biosynthesis
in the presence or absence of exogenous ACTH.
Plasma 25-hydroxyvitamin D deficiency in rats with mild
chronic renal failure. B. Garcia, A. Celada, D. Depierre, A.
Balant, J. M. Very, H. Favre. Département de Médecine et
Institut de Morphologic, Université de GenCve, Switzerland. To
assess if the deficiency of 25-hydroxyvitamin D (25-OH-D) in
chronic renal failure (CRF) is due to a poor vitamin D intake, as
suggested previously, rats have been studied in metabolic cages, 6
months following sub-total nephrectomy or sham-operation. Vita-
min I) intake was the same in CRF and control rats.
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No significant differences were found in bone lattice cell parame-
ters between the two groups.These results show that 25-OH-D
deficiency is present in this moderate CRF rat model, in spite of an
adequate vitamin D intake.
Properties of an amphibian (Na, K)-ATPase (EC 3.6.1.3). K.
Geering and B. C. Rossier. Institut de Pharmacologic de
l'UniversitC, Lausanne, Switzerland. Transport adenosine triphos-
phatase [(Na, K)-ATPase] has been purified and characterized
from fish, birds, and mammals. We purified partially (Nat, K)-
ATPase from the kidney of the toad Bufo marinus. Treatment of
micro somes with dodecyl sulfate (0.45 mg SDS/ml. 1.4mg proteinl
ml) and subsequent centrifugation through a non-linear sucrose
gradient (10%, 15%, 29.4% sucrose) yielded an enzyme with a
specific activity of 450—800 rmoles inorganic phosphate (P1)/mg of
protein/hr (0.8—1 mg of proteinlg tissue) compared to 40—70 z
moles P1/mg/hr of the microsomal fraction. The major band on
SDS polyacrylamide slab gels showed an apparent mol wt of
110,000. This band was identified by autoradiography after incor-
poration of ATy32P into the partially purified enzyme in the pres-
ence of sodium, as the catalytic subunit of the (Nat, K-)-ATPase.
No phosphorylated intermediate was formed in the presence of
potassium. Sodium, potassium, and adenosine triphosphate con-
centrations for half-maximal activation (Km) of the partially puri-
fied enzyme were 12 mM, 1.1 mai, and 0.46 m, respectively (3
different preparations). These characteristics of toad kidney (Na,
K)-ATPase are similar to those found in other phyla. The enzyme
does not appear to have undergone major alteration with evolution
from amphibians to mammals.
Renal response to parathyroid hormone in rats: Influence of
1,25-dihydroxyvitamin D3. H. J. Gloor, J. P. Bonjour, and H.
Fleisch. Pathophysiologisches Institut der Universitdt Bern, Bern,
Switzerland. Recently, we have observed that in thyroparathyroid-
ectomized (TPTX) rats fed low (0.2 g/100 g) phosphorus diet, the
tubular phosphaturic response to parathyroid hormone (PTH) re-
mains markedly blunted, even when it is assessed at normal or
high plasma concentration and filtered load of inorganic phosphate
(P1). Since 1 ,25-dihydroxyvitamin D3 (1 ,25-(OH)2D3) chronically
administered to TPTX rats enhances the tubular capacity to ex-
crete P1, we have studied whether this vitamin D3 metabolite could
specifically increase the phosphaturic response to PTH in phos-
phate-deprived animals. The results indicate that in vitamin D-
replete TPTX rats fed low (0.2 g%) phosphorus diet, l,25-(OH)2D3
given chronically (2 x 13 pmoles/day, i.p., for 7 days) enhances
markedly the acute tubular phosphaturic response to PTH (2.5 IU/
hr, i.v., for 75 mm). In contrast, 1,25-(OH)2D3 treatment enhances
neither the urinary cAMP response nor the tubular hypocalciuric
response to PTH. Furthermore, under the same conditions of low
P, diet in TPTX rats, 25-hydroxyvitamin D3, even in doses 100
times (2 x 1300 pmoles/day, i.p., for 7 days) larger than 1,25-
(OH)2D3, did not restore the blunted phosphaturic response to
PTH. In conclusion, 1,25-(OH)2D3 administration, like dietary P1,
influences markedly the acute action of parathyroid hormone on
phosphate but not on cAMP and calcium excretion.
Renal effect of hypoxemia during angiotensin II inhibition. J. P.
Gui gnard and B. Filloux. Service de pediatric, CHUV, Lausanne,
Switzerland. In the rabbit, acute normocapnic hypoxemia in-
6.15 0.64 3.56 1.05 <0.005
32.4 5.7 14.9 6.1 <0.005
3.45 0.89 8.54 1.93 <0.001
2.40 0.005 2.30 0.1 NS
0.030 0.025 0.047 0.028 NS
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creases renal vascular resistance, leading to renal hypoperfusion
and decreased water and electrolyte excretion. This effect is more
pronounced during severe hypoxemia. Participation of the renin-
angiotensin system in the renal defects observed during hypox-
emia was studied in pentobarbital-anesthetized rabbits infused
with saralasin (1-Sar-8-Ala-AII), a specific antagonist of angioten-
sin II. Saralasin was infused at a rate of 5 rg/kgx mm before and
after inducing moderate or severe acute hypoxemia. In control
animals, infusion of saralasin for 4 hours did not change systemic
blood pressure (BP), urine flow, glomerular filtration rate (GFR),
effective renal plasma flow (ERPF), or electrolyte excretion. Dur-
ing angiotensin II blockade, moderate hypoxemia (arterial oxygen
tension [Po2] = 44 mm Hg) did not induce any change in BP, urine
flow, GFR, ERPF, or electrolyte excretion. Competitive inhibition
of angiotensin II thus appears to prevent the renal effects of
moderate hypoxemia. This suggests that the increased vascular
resistance normally seen during moderate hypoxemia is mediated
via angiotensin II release. Severe hypoxemia (Po2 = 39 mm
Hg) produced metabolic acidosis and a decrease of systemic blood
pressure from 87 to 68 mm Hg. In this condition, saralasin infusion
could not prevent the effect of severe hypoxemia on renal func-
tion: GFR decreased from 2.31 to 1.13 (P < 0.001) and ERPF from
7.45 to 4.23 mI/kg >< mm (P < 0.01). The slight decrease in water
and electrolyte excretion was not significant. Angiotensin II inhibi-
tion thus blunts the effect of severe hypoxemia on water and
electrolyte excretion, but does not prevent the marked depression
of GFR and ERPF. These latter two defects thus appear to be
related both to systemic hypotension and metabolic acidosis, and
to local vasoconstriction.
Efficacy and limitations of minoxidil therapy in refractory hy-
pertension. G. Keusch, P. Weidmann, V. Campese, D. Lee, and
S. G. Massry. Medizinische Poliklinik, University of Berne, Switz-
erland, and University of Southern California, Los Angeles, Cali-
fornia. Minoxidil (M) is an oral vasodilator, which has been used
successfully in the treatment of patients (pts) with refractory
hypertension (RH). In order to further evaluate the efficacy and
limitations of M, blood pressure (BP) and side effects were ana-
lyzed in 155 pts with RH (12 our own, 143 reported by others). The
majority (88%) had impaired renal function; 51% were uremic,
requiring dialysis. The indication for the use of M was severe RH
(diastolic BP 110 mm Hg) and ineffectiveness (71%), and/or
dose-limiting side effects (29%) of conventional antihypertensive
agents. Most pts had also target organ damage. With M, BP
dropped from 196/126 to 151/90 mm Hg. The mean dose of M to
achieve this was 25 mg/day. Both the BP response and the mean
dose of M required were unrelated to pretreatment level of BP or
presence or absence of renal failure or underlying renal disease.
Although 58% of pts were resistant to 4 to 6 different antihyperten-
sive drugs before M, BP following the addition of M was con-
trolled with 2 or 3 drugs in 82% (M, beta-blocker or sympathetic
suppressant, diuretic or dialysis). During M therapy, sympatho-
lytic agents could be discontinued or their dose reduced; this led to
marked improvement of orthostatic hypotension, a frequent side
effect before M. Relevant side effects of M occurred in 56% of pts.
These included hypertrichosis (26%), edema (16%), congestive
heart failure (8%), and angina pectoris (5%). In 12%, hypertri-
chosis (2%), edema or congestive heart failure (8%), or angina
pectoris, claudicatio intermittens or postdialysis hypotension
(each 0.7%) necessitated discontinuation of M. Treatment with M
in combination with a beta-blocker and a diuretic is effective in
controlling RH, irrespective of the pretreatment BP and the pres-
ence or absence of renal failure, but this therapy may often have
relevant side effects.
Delayed partial recovery of renal function after a hemolytic and
uremic syndrome in a woman given oral contraceptives. M. Leski,
B. Ody, H. Favre, and F. Moser. Division de Néphrologie, Dé-
partement de Médecine, Hôpital Cantonal, Geneva, Switzerland.
The case of a 42-yr-old female on oral contraceptives, who was
hospitalized in emergency with an accelerated hypertension and
renal failure, is reported. The diagnosis of hemolytic and uremic
syndrome (HUS) was made on clinical and biological grounds. No
renal biopsy was performed. The patient first received only antihy-
pertensive drugs and hemodialysis. After one month dipyridamole
and aspirin were added to the treatment. Neither heparin nor
dicoumarin were used at any time. After one year, renal function
had improved sufficiently to allow discontinuation of the dialysis,
although the blood pressure was more difficult to control. This
observation stresses the fact that, despite the usual irreversible
evolution of HUS in adults, especially in women taking contracep-
tive drugs, spontaneous partial recovery of the renal function may
occur, even after a long delay.
Progression of renal insufficiency in pediatric patients: Estima-
tion by serum creatinine. Ernst P. Leumann. Universiläts-Kin-
derklinik, Zurich, Switzerland. Sequential serum creatinine (Scr)
determinations, obtained from the Swiss Survey on Chronic Renal
Insufficiency in Childhood, were evaluated in 45 patients by plot-
ting the logarithm of S (log Scr) or the reciprocal (l/Scr) time.
Linear regression analysis was performed on data of 38 patients
with 4 to 9 sequential S values. A straight line relationship on
both plots was observed in 24 patients. In contrast, the semilog
plot appeared more suitable in 2, and the reciprocal plot in 7
instances. In 5 patients, progression of renal insufficiency was
clearly non-linear. Mean progression rates in various disease cate-
gories, expressed as Scr doubling time (on the semilog plot), were
2.4 months in 10 patients with acquired (glomerular) diseases, 17
months in 3 patients with cystinosis, 27.7 months in 5 patients with
renal hypoplasia and dysplasia, and 21.8 months in 13 patients with
urinary tract abnormalities. It is concluded that both models are
applicable in the majority of pediatric patients, and that loss of
renal function usually occurs either exponentially (log Scr) or at a
constant rate (l/Scr). Both plots appear useful for prediction of the
time at which dialysis will be required.
Interaction of thyroid hormone with the action of aldosterone on
sodium transport in toad bladder. B. C. Rossier, H. P. Gaggeler,
and M. Rossier. Institut de Pharmacologie de I' Université, Lou-
sanne, Switzerland. Thyroid hormone administered in vivo (2sg/
100 g of body wt per day for 6 days) significantly lowered the basal
rate of sodium transport in the urinary bladder of the toad (Bufo
marinas). This finding raises the possibility of a direct interaction
between thyroid hormone and aldosterone on the target cell.
Therefore, the effects of triiodothyronine (T3) and aldosterone (A)
on sodium transport were studied in vitro by the short-circuit
current technique (SCC). Two protocols were used 1) T3 vs.
diluent and 2) (T3 -t A) vs. (A). T3 at a final concentration of 0.6
nM, 6 n or 60 n was added 2 hr before aldosterone (80 nM) and
the change in SCC followed for 8 hr. 1) T3 had no significant effect
on the baseline SCC up to 10 hr of incubation ( A = —14 11;P > 0.3; N = 10). 2) T3 did not inhibit the response to A for 3 hr,
but entailed a major depression of the A effect thereafter. Maxi-
mum inhibition was present at 6 nM T3 ( tA = —77±25; P
<0.01; N = 10). Thyroid hormone, thus, might regulate the late
mineralocorticoid response at the level of its target cell but does
not interfere with the initial response. This effect might be of
physiologic relevance considering a plasma T3 (measured by ra-
dioimmunoassay) of 0.3 to 0.8 nM in this species.
Gentamicin-induced acute renal failure (ARF) in the rat. D. de
Rougemont, G. Konrad, A. Oeschger, J. Torhorst, F. Brunner, G.
Thiel. Departement für Innere Medizin, Universitht Basel, Switz-
erland. ARF was induced by subcutaneous injections of 200 mg/kg
of body wt of gentamicin on 3 consecutive days. The animals
developed polyuria and usually remained polyuric up to sacrifice at
2, 7, or 14 days after the last dose of gentamicin. Blood urea rose to
141 25(N = 8)at2,643 l88(N = 8)at7 and returned to 49
3 mg/lOO ml (N = 8) at 14 days (BU was 36 3 in five normal
controls. Proximal tubular pressure (PIP) (servo-nulling device)
and proximal transit time (PIT) (lissamine green i.v.) were mea-
sured at 2, 7, and 14 days. The kidney surface had a normal
appearance on the second day after gentamicin, when average PTP
was slightly increased to 13.7 0.5mm Hg (N = 79) (11.6 0.2
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[N = 521 in controls) while PTT was 9.1 1.0 sec (N = 14) and
thus identical to the control average of 9.1 0.8 (N = 15). At 7
days many opaque convolutions were seen on the surface of the
kidney; FTP was markedly decreased to 6.1 0.4 (N = 85), and
no discernible color wave moving down to the tubules was ob-
tained after injection of lissamine green. At 14 days, no opaque
tubules were present; PTP with 11.6 0.2 (N = 52) and PFT with
10.6 0.8 (N = 12) were back to normal. Conclusions. 1) Brisk
tubular flow and only marginally increased PTP exclude significant
tubular obstruction as a cause of decreased renal function in the
early phase. 2) Low PTP at the peak of renal failure could be
explained by primary filtration failure or by passive back flow
through leaky necrotic tubular walls or both.
Treatment of digoxin intoxication with charcoal hemoperfusion.
J. Tuma, K. Záruba, and F. Dorschner. Haemodialyse-Station
andMedizinische Klinik, Stadtspital Waid, Zurich, Switzerland. A
case of severe digoxin intoxication and its successful treatment by
hemoperfusion with activated charcoal (Haemocol) is reported. A
patient with chronic renal failure (Ccr = 12 mI/mm) attempted
suicide by taking 100 digoxin tables (0.25 mg/tablet). Over a period
of 20 hr, two charcoal hemoperfusions (four hours each) were
performed. During each procedure, serum digoxin levels were
lowered from 7.1 .tg/liter to 5.2gI1iter and from 4.9 to 4.2 pg/liter,
respectively. Clearance of digoxin was 34.7 mi/mm and 72.0 ml/
mm, respectively. Total elimination constants during the days of
hemoperfusion were 0.015/hr and 0.023/hr, respectively. These
elimination constants were significantly higher than those ob-
served during the next four days (mean elimination constant,
0.009/hr). No severe adverse effects were observed. These results
indicate that charcoal hemoperfusion may be employed for acute
digoxin intoxication.
Remn and hemodynamic effects of saralasin in normotensive
patients with chronic congestive heart failure. G. Turini, H. Brun-
ner,R. Ferguson, J. Rivier, and H. Gavras. Department of Mede-
cine, Centre Hospitalier Universitaire, Lausanne, Switzerland.
The role of the renin-angiotensin system was evaluated in 18
normotensive patients with chronic congestive heart failure and in
5 controls. No correlation was observed between plasma renin
activity and cardiac index. There was a significant inverse correla-
tion between renin and pulmonary capillary wedge pressure (r =
—0.61, P < 0.01). Renin values of the patients appeared to be
increased when compared to controls with comparable left ventric-
ular filling pressure. Specific angiotensin II inhibition by saralasin
decreased arterial pressure in 8 out of 14 patients (— 11 3 mm
Hg). Their renin was significantly higher (8 2 ng/ml/hr) than that
of the remaining 6 patients (1.9 1 ng/ml/hr) (P <0.01). The two
patients with the lowest renin levels (<1.2 ng/ml/hr) responded to
saralasin with a blood pressure increase. Left ventricular filling
pressure decreased (—6 1 mm Hg) in all but these latter 2
patients, with either little change or an increase in the stroke
volume. Thus, renin levels appear to be increased in normotensive
patients with congestive heart failure when related to left ventricu-
lar fifing pressure. Renin via angiotensin II plays a role in the
blood pressure control of many patients with congestive heart
failure. Angiotensin II blockade can improve cardiac function by
unloading the left ventricle.
How to treat 50 new hemodialysis patients per year per million
population. J. P. Wauters, H. R. Brunner, and J. F. Boudiy.
Department de Médecine, Centre Hospitalier Universitaire, Lau-
sanne, Switzerland. Because of the constantly increasing number
of hemodialysis patients, treatment programs must be adapted to
make hemodialysis available to all patients at lowest possible cost.
To achieve this goal, the following approach is used: I) An inte-
grated hemodialysis program has been set up which includes a
traditional center (40% of our patients), a home (25%), and a self-
care dialysis (35%). Self-care dialysis is performed in local hospi-
tals within the area covered by our renal unit. Self-care patients,
trained identically as for home-dialysis, carry out the complete
procedure with a non-specialized nurse assisting at the beginning
and the end of each session. There is no difference in clinical and
biological parameters between center and self-care dialysis pa-
tients: travel time is reduced by 80% and cost of dialysis by 50%.
2) To further reduce cost, dialyzers of all (including center) patients
are reused ("one kidney per week"). The re-use techniques are
manual at home and in self-care, and they are semi-automated in
the center. No long-term adverse clinical or biologic effects have
been observed. Application of this integrated hemodialysis pro-
gram makes dialysis available to all patients without increasing
dialysis staff or expanding the center; we now accept 25 new
patients per year out of a population of 500,000. Moreover, a
reduction of the average cost of dialysis by more than 30% has
been obtained without compromising on the quality of the dialysis
treatment.
Comparison of blood loss in coil dialyzers after intermittent
(Ill), continuous (CH), regional (RH), and minimal-intermittent
(Mifi) heparinization. P. Willimann, A. Aug and U. Binswanger.
Departement für Innere Medizjn der Universität Zurich, Switzer-
land. After rinsing with 800 cc of saline, residual blood volume in
Ex-25 and coil dialyzers were estimated by measuring coil radioac-
tivity in a large volume scintillation counter and comparing the
radioactivity to that measured in 2 ml of 51Cr labelled erythrocytes
from the same patients. Paired studies were done in 10 patients in
order to compare losses after MIH (monitored by the partial
thromboplastin time) and 3 other procedures of heparinization moni-
tored by the thrombin time). Results were as follows (ml; mean SD):
MIH vs. IH, 2.9 1.7 vs. 2.2 0.3; MIH vs. CH, 2.8 1.7 vs. 2.1
0.5; MIH vs. RH, 2.0 0.5 vs. 2.0 0.3. Paired data are not
significantly different. The doses of heparin used during 5 hours of
dialysis were: MIH, 4000 1000 (IU); IH, 8700 1100; CH, 5600
400; RH, 22000 1100. No bleeding occurred in 10 high risk
patients during 50 hemodialyses. MIH does not increase blood loss
in the dialyzer but reduces the dosage of heparin, avoids infusion-
pumps and protamin sulfate.
